baclofen has been researched along with Bile Duct Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saengboonmee, C | 1 |
| Sorin, S | 1 |
| Sangkhamanon, S | 1 |
| Chomphoo, S | 1 |
| Indramanee, S | 1 |
| Seubwai, W | 1 |
| Thithuan, K | 1 |
| Chiu, CF | 1 |
| Okada, S | 1 |
| Gingras, MC | 1 |
| Wongkham, S | 1 |
1 other study available for baclofen and Bile Duct Cancer
| Article | Year |
|---|---|
γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus.
Topics: Baclofen; beta Catenin; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Prolif | 2023 |